The Compounding Tortoise

The Compounding Tortoise

Share this post

The Compounding Tortoise
The Compounding Tortoise
Q1 2025 - Lifco - Analysis

Q1 2025 - Lifco - Analysis

Regaining lost ground from Q1 2024 - off to a softer M&A start in FY25

The Compounding Tortoise's avatar
The Compounding Tortoise
Apr 25, 2025
∙ Paid
11

Share this post

The Compounding Tortoise
The Compounding Tortoise
Q1 2025 - Lifco - Analysis
3
Share

The leading Swedish serial acquirer, Lifco AB, reported Q1 results this morning. At the time of writing, the stock’s up 4%.

Favorable Comparison and Stabilizing Market Conditions

It reported a strong 8.1% organic revenue increase, which was helped by a favorable comparison vs. Q1 last year and timing of Easter. Essentially, Lifco was able to mostly recoup lost ground from last year’s -7.8% organic revenue growth.

Additionally, exceptionally strong performance for its lower-margin Contract Manufacturing segment continued (+94.5%), although CEO Waldemarson noted a weaker start in April, which doesn’t necessarily have to paint a dire picture for Q2. If volumes were to weaken more meaningfully, it would take some months to adjust the expense structure and maintain profitability. Historically, Lifco’s been quite fast with expense control. The wild card is that the situation on tariffs is fluid, and it’s difficult to predict the impact on demand in Lifco’s major end markets. So far in April, order flow has been fairly strong.

Let’s take a closer look at the quarter, and update our valuation model.

At the end of this article, we’ll share our current portfolio’s ratings (i.e. HOLD, UNDERWEIGHT, STRONG BUY, BUY). These ratings could help you figure out which stocks present attractive buying opportunities and where we think it’s prudent to maintain an underweight allocation.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 The Compounding Tortoise
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share